- Study finds most smokers lack knowledge on ways to quit smoking
- Harvard School survey asserts NRT ineffective in spite of body of evidence to the contrary
- Report: Nicotine replacement product sales to reach $6.2 billion worldwide by 2018
- FDA studies effectiveness, benefits of long-term smoking-cessation therapy
- Sam's Club unveils New Year's resolutions-based health screenings program
PARSIPPANY, N.J. — The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.
Quit.com is described as a "total quit-smoking online resource" that includes features to help smokers create personalized plans for quitting without relapsing.
"Quitting smoking is tough and requires focus and effort, but that's only half the equation," University of Pittsburgh addiction researcher and paid consult to GSK Saul Shiffman said.
The company noted that 15 million smokers try to quit each year, but only 5% succeed when they go cold turkey or use no support.